# Ketogenic Diet Adjunctive to HD-MTX Chemotherapy for Primary Central Nervous System Lymphoma

> **NCT02983942** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Beijing Tiantan Hospital** · enrollment: 50 (estimated)

## Conditions studied

- Primary Central Nervous System Lymphoma

## Interventions

- **DIETARY_SUPPLEMENT:** ketogenic diet
- **DIETARY_SUPPLEMENT:** Routine diet

## Key facts

- **NCT ID:** NCT02983942
- **Lead sponsor:** Beijing Tiantan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-01
- **Primary completion:** 2018-12
- **Final completion:** 2019-12
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2016-12-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02983942

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02983942, "Ketogenic Diet Adjunctive to HD-MTX Chemotherapy for Primary Central Nervous System Lymphoma". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT02983942. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*